ERC-Funded Post-doctoral Researchers in Stem Cell Research / Wickström Lab
Posted by Kate Miroshnikova, on 23 May 2018
Closing Date: 15 March 2021
The group of Sara Wickström, funded by an ERC Consolidator Grant in 2018, is looking for
ERC-Funded Post-doctoral Researchers in Stem Cell Research
for 2 years starting from 1.8.2018 with possibility of extension up to 4 years.
We are looking for talented and highly motivated scientists to join a young and dynamic research team in the analysis of stem cell regulation in tissue morphogenesis, maintenance and cancer. We employ a wide range of techniques, including mouse genetics, organoid and bioengineering tools, live cell imaging, mass spectrometry and single cell sequencing to study how stem cell and cancer stem cell fate is regulated through interactions with their niche.
The applicant is required to hold PhD in biology, genetics, bioengineering, biochemistry, or a related field, as well as strong written and oral communication skills. The working language is of the lab is English; knowledge of the Finnish language is not necessary. Experience in cell biology is required, experience in computational data analysis and next generation sequencing is an advantage.
To apply:
To apply, please submit your application using the University of Helsinki electronic recruitment system https://www.helsinki.fi/fi/avoimet-tyopaikat/post-doctoral-researchers-in-stem-cell-research. Upload a single pdf-file containing a one-page letter with a personal statement outlining your research interests and relevant work experience, your CV and bibliography, contact information for 2-3 references.
Informal inquiries are very welcome and should be sent to sara.wickstrom@helsinki.fi. For more information on the Wickström lab see https://www.helsinki.fi/en/researchgroups/stem-cells-and-tissue-architecture , twitter:@WickstromLab
About HiLIFE:
Helsinki Institute of Life Science, HiLIFE, is a new life science institute at the University of Helsinki, a leading Nordic university with a strong life science research. HiLIFE operates mainly in the campuses of Meilahti and Viikki. In Meilahti, top-notch medical research, education and care meet daily to benefit of the patients and the entire society. Meilahti provides access to state of the art core facilities for imaging, genomics, proteomics and metabolomics, as well as bioinformatics. It is also home to the Faculty of Medicine and the Helsinki University Central Hospital (HUCH) which makes it an interactive research community with interests in a broad range of topics from fundamental biology to clinical applications.